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Abstract
Ectopic calcification (EC), which is the pathological deposition of calcium and phosphate in
extra-skeletal tissues, may be associated with hypercalcaemic and hyperphosphataemic
disorders, or it may occur in the absence of metabolic abnormalities. In addition, EC may be
inherited as part of several monogenic disorders and studies of these have provided valu-
able insights into the metabolic pathways regulating mineral metabolism. For example,
studies of tumoural calcinosis, a disorder characterised by hyperphosphataemia and pro-
gressive EC, have revealed mutations of fibroblast growth factor 23 (FGF23), polypeptide
N-acetyl galactosaminyltransferase 3 (GALNT3) and klotho (KL), which are all part of a
phosphate-regulating pathway. However, such studies in humans are limited by the lack of
available large families with EC, and to facilitate such studies we assessed the progeny of
mice treated with the chemical mutagen N-ethyl-N-nitrosourea (ENU) for EC. This identified
two mutants with autosomal recessive forms of EC, and reduced lifespan, designated
Ecalc1 and Ecalc2. Genetic mapping localized the Ecalc1 and Ecalc2 loci to a 11.0 Mb re-
gion on chromosome 5 that contained the klotho gene (Kl), and DNA sequence analysis
identified nonsense (Gln203Stop) and missense (Ile604Asn) Klmutations in Ecalc1 and
Ecalc2mice, respectively. The Gln203Stop mutation, located in KL1 domain, was severely
hypomorphic and led to a 17-fold reduction of renal Kl expression. The Ile604Asn mutation,
located in KL2 domain, was predicted to impair klotho protein stability and in vitro expres-
sion studies in COS-7 cells revealed endoplasmic reticulum retention of the Ile604Asn mu-
tant. Further phenotype studies undertaken in Ecalc1 (kl203X/203X) mice demonstrated
elevations in plasma concentrations of phosphate, FGF23 and 1,25-dihydroxyvitamin D.
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Thus, two allelic variants of Kl that develop EC and represent mouse models for tumoural
calcinosis have been established.
Introduction
Ectopic calcification (EC) is characterized by the pathological deposition of calcium and phos-
phate in extra-skeletal tissues, and represents a major cause of adverse cardiovascular outcomes
and mortality [1]. Two types of EC, referred to as metastatic and dystrophic EC, are recognised.
Metastatic EC is associated with metabolic abnormalities and arises from sustained elevations
in circulating calcium and/or phosphate concentrations, which lead to widespread mineral de-
position that particularly affects arterial vessels, kidneys, articular cartilage and peri-articular
soft tissues [2], and occurs frequently in major chronic diseases such as chronic renal failure
[3]. Dystrophic EC occurs in the absence of systemic metabolic derangements and may repre-
sent a response to tissue injury, as highlighted by connective tissue disorders such as scleroder-
ma [2]. In addition, EC may be inherited as part of a monogenic disorder and studies of these
diseases have provided valuable insights into the molecular basis and metabolic pathways caus-
ing EC. For example, studies have highlighted the central role of pyrophosphate as a minerali-
zation regulator, as germline mutations of the ectonucleotide pyrophosphatase/
phosphodiesterase 1 (ENPP1) gene, which encodes an enzyme mediating the generation of ex-
tracellular pyrophosphate, lead to idiopathic infantile arterial calcification [4], whilst germline
mutations of the ANKH gene, which encodes a transmembrane protein involved in pyrophos-
phate transport, may lead to chondrocalcinosis [5]. In addition, studies of tumoural calcinosis
(TC), an autosomal recessive disorder characterized by the progressive deposition of calcium
phosphate crystals in peri-articular and other soft tissues [6], have revealed hyperphosphatae-
mia to be a major promoter of ectopic calcification and delineated a hormonal mechanism reg-
ulating circulating phosphate concentrations [6, 7]. Molecular genetic studies of patients and
families with TC have identified the occurrence of mutations of either the fibroblast growth
factor 23 (FGF23), polypeptide N-acetyl galactosaminyltransferase 3 (GALNT3), or klotho
(KL) genes, which all encode proteins involved in a phosphate-regulating pathway [8–13].
Thus, FGF23 is a secreted osteocyte protein, whose post-translational processing requires
GALNT3 mediated mucin type O-glycosylation, and which acts on the renal tubule via a mem-
brane protein complex comprising the FGF receptor (FGFR) and a co-receptor, known as
klotho, to promote renal phosphate excretion by downregulating type II sodium-phosphate co-
transporters. FGF23 also decreases intestinal phosphate absorption by inhibiting the renal vita-
min D-1α-hydroxylase (Cyp27b1) mediated synthesis of 1,25-dihydroxyvitamin D [6, 7]. The
human KL gene encodes a parathyroid and renally expressed 1012 amino acid type 1 trans-
membrane protein with a 980 amino acid extracellular domain comprised of two internal re-
peat regions, termed KL1 and KL2 [11, 14] that share homology to the β-glycosidase enzyme
family [15, 16] and mediate protein-protein interactions with FGFR [17]. Studies aimed at
identifying further genetic abnormalities causing EC in humans are hampered by the lack of
available large families with monogenic forms of EC that could facilitate positional cloning
studies. To overcome these difficulties and facilitate the identification of genetic abnormalities
causing EC, we embarked on establishing mouse models using N-ethyl-N-nitrosourea (ENU),
which is a chemical mutagen that causes point mutations by alkylation of nucleic acids leading
to mispairing and subsequent single base substitutions during DNA replication [18]. ENU
mouse mutants, which can be associated with loss-of-function, hypomorphic, hypermorphic
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or dominant-negative allelic variants, have been successfully derived for metabolic disorders
[19–21]. An example is our previously reported ENU mouse model for TC due to a Trp589Arg
missense mutation of the Galnt3 gene [20]. We now report the identification of two new ENU-
induced mouse mutant models for TC, designated kl203X and kl604N due to mutations located
within the Kl coding-region. Previously, transgenic mice with hypomorphic Kl alleles (kl/kl
mice) and kidney-specific Kl null (Six-2-kl-/-) mice, that had hyperphosphataemia, EC and
shortened lifespan have been reported [11, 22] (Table 1), and thus our findings of these ENU-
induced mouse mutants represents the first report of EC mouse models with Kl coding se-
quence mutations, which will help to further elucidate the molecular basis of klotho function
and characterise the role of the FGF23-klotho pathway in the renal regulation of phosphate
metabolism.
Materials and Methods
Ethics Statement
All animal studies were carried out using guidelines issued by the Medical Research Council in
'Responsibility in the Use of Animals for Medical Research' (July 1993) and UK Home Office
Project License Number 30/2433. Experiments were approved by the Medical Research Coun-
cil Harwell ethics committee.
Generation and Initial Characterisation of Mutant Mice
Male C57BL/6J mice were treated with ENU and mated with untreated C3H/HeH female mice
[18]. The male progeny (G1) were subsequently mated with wild-type C3H/HeH females to gen-
erate G2 progeny. The female G2 progeny were then backcrossed to their G1 fathers and the re-
sulting G3 progeny [18] were screened from 2 weeks of age for recessive phenotypes. Mice were
fed an expanded rat and mouse no. 3 breeding diet (Special Diets Services, Witham, UK)
Table 1. Comparison of mousemodels and patient harbouring klothomutations.
kl203X/203X mice kl/kl mice Six2-kl-/- mice Patient with KL mutation
Reference - [9, 27, 29] [28] [7]
Mutation type Germline (homozygous)
nonsense
Germline hypomorphic/
null
Kidney-speciﬁc
null
Germline (homozygous)
missense
Ectopic calciﬁcation + + + +
Osteopaenia + + + +
Growth retardation + + + -
Pulmonary emphysema + + + -
Skin atrophy + + + -
Hearing loss + + NK -
Plasma/serum biochemistry:
Calcium Normal " " "
Phosphate " " " "
Alkaline phosphatase
activity
" NK NK Normal
1,25-dihydroxyvitamin D " " " "
Fibroblast growth factor 23 " " " "
Parathyroid hormone NK # # "
Glucose # # NK NK
+, present;-, absent; #, reduced; ", increased; NK, not known.
doi:10.1371/journal.pone.0122650.t001
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containing 1.15% calcium, 0.82% phosphate and 4088.65 units/kg vitamin D, and given water
ad libitum. Wild-type littermates were used as controls, as these would have similar random as-
sortments of segregating C57BL/6J and C3H alleles, to those of the mutant mice, thereby mini-
mising any strain-specific influences. Initial assessment of the G3 progeny comprised a
dysmorphology screen to assess for gross anatomical changes and auditory function [23, 24], fol-
lowed by digital radiography and the dissection of tissues for histological analysis [20, 25].
Genome-wide mapping was performed once the progeny had been investigated using these
procedures.
Plasma Biochemistry
Blood samples were collected from the retro-orbital sinus after terminal anaesthesia, and plas-
ma was separated by centrifugation at 3000 g for 5 min at 4°C. Plasma samples were analysed
for total calcium, inorganic phosphate, urea, albumin, glucose, alkaline phosphatase and ala-
nine transaminase activities, on a Beckman Coulter AU680 semi-automated clinical chemistry
analyzer, as described [25]. Plasma calcium was corrected for albumin using the formula:
((albumin-mean albumin) x0.02) + calcium), as reported [25]. Intact FGF23 was quantified
using a two-site ELISA kit (Kainos Laboratoties, Tokyo, Japan), and 1,25-dihydroxyvitamin D
was measured by a two-step process involving purification by immunoextraction and quantifi-
cation by enzyme immunoassay (Immunodiagnostic Systems, Boldon, UK), as described [25].
Imaging by Radiography and Dual-energy X-ray Absorptiometry
Mice or dissected specimens were subjected to digital radiography at 26kV for 3 seconds using
a Faxitron MX-20 digital X-ray system (Faxitron X-ray Corporation), and images were pro-
cessed using the DicomWorks software (http://www.dicomworks.com/), as previously reported
[20]. Dissected femora were scanned by dual-energy X-ray absorptiometry (DXA) using a
Lunar PIXImus densitometer (GE Medical Systems) and images were processed using the PIX-
Imus software [20].
Analysis of Auditory Function
Mice were exposed to a high frequency tone stimulus emitted from a handheld click-box, as de-
scribed [23], and their hearing ability assessed by the presence of a ‘Preyer’ reflex in the pinnae,
which flick backwards to indicate normal hearing.
Histology
Dissected specimens were fixed in 10% formalin, bones decalcified in formical-4 (Decal Chem-
ical Corporation) for 3 days before embedding in paraffin wax. Soft tissue sections (3–4 μm)
were stained with haematoxylin and eosin (H&E) or von Kossa, whereas bone sections were
stained with van Gieson and alcian blue 8GX, as described [20]. Digital images were obtained
using the Nanozoomer 2.0 Digital Pathology system (Hamamatsu Photonics, Welwyn Garden
City, UK). Auditory ossicles were dissected from wild-type and mutant mice and their mor-
phology assessed by microscopy.
Mapping, DNA Sequence Analysis and Genotyping
Genomic DNA was extracted from auricular or tail biopsies, as described [20]. For genome-wide
mapping, genomic DNA was amplified by PCR using a panel of 91 single nucleotide polymor-
phism (SNP) loci arranged in chromosome sets, and the products were analysed by pyrosequen-
cing, as described [20]. Individual exons of Kl were amplified from genomic DNA by PCR using
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gene-specific primers and Taq PCRMastermix (Qiagen, Crawley, UK), and the PCR products se-
quenced using BigDye terminator reagents and ABI 3100 sequencer (Life Technologies, Carls-
bad, USA). For genotyping, DNA was amplified using Taq PCRMastermix (Qiagen, Crawley,
UK), as described [20]. Primers utilized to amplify exon 1, which contained the kl203Xmutation
were: forward 5’- CCCACTACCGCTTCTCCATA -3’ and reverse 5’- AGTAGGTTGTGGG-
CAACCAG-3’. Primers utilized to amplify exon 4, which contained the kl604Nmutation were:
forward 5’-GCTAACAGTTGCTCTGTTCTTTG-3’ and reverse 5’- CCACCACTGGAGT-
GATGTTG -3’. PCR products were digested with PstI andDpnII restriction enzymes, respec-
tively, and separated by agarose gel electrophoresis before image acquisition using a Gel Doc UV
transilluminator (Bio-Rad, Hemel Hempstead, UK), as described [26].
In vitro Studies of Cellular Localisation
Total RNA was isolated from kidneys of wild-type mice using the RNeasy mini kit (Qiagen,
Crawley, UK) and 2 μg was used to synthesize cDNA using AffinityScript multiple temperature
reverse transcriptase (Agilent Technologies, Edinburgh, UK) using methods previously de-
scribed [20]. The full-length membrane-bound form of mouse wild-type Kl cDNA was ampli-
fied with Easy A (Agilent Technologies, Stockport, UK) using the forward primer (5’- CTC
AAG CTT GCT CCC GCA GCA TGC TAG CC -3’) and the reverse primer (5’- GCAG AAT
TCG CTT ATA ACT TCT CTG GCC TTT C -3’), and the PCR product sub-cloned into
pEGFP-N1 (Clontech, Saint-Germain-en-Laye, France) [27]. The kl604N mutation was intro-
duced using site-directed mutagenesis with the forward primer 5’- AC TGG GCC CTG AAC
TTG CCT CTG GGT -3’ and its reverse complement, and DNA sequence analysis of the con-
structs was undertaken, using previously reported methods [27]. The wild-type and mutant Kl
constructs (1μg of each construct) were transiently transfected into COS-7 cells using jetPEI re-
agent (Polyplus Transfection, Illkirch, France) and expression visualized by immunofluores-
cence staining using anti-Golgi matrix protein (GM130) (BD Bioscience, Oxford, UK) or
mouse anti-protein disulphide isomerase (PDI) (Enzo Life Science, Exeter, UK) under confocal
microscopy, as reported [20]. Western blot analysis was performed using equal amounts of
proteins from untreated or enzymatically deglycosylated lysates from transfected COS-7 cells
[20]. Briefly, lysates were boiled for 10 min in denaturing buffer (0.5% SDS, 40mM DTT), and
treated with endoglycosidase (Endo) H (New England Biolabs, Ipswich, UK). Samples were
separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), electro-
blotted onto nitrocellulose membrane (GE Healthcare, Little Chalfont, UK), probed with
mouse anti-GFP antibody (Roche Diagnostics, Burgess Hill, UK) followed by HRP-conjugated
goat anti-mouse IgG (Bio-Rad, Hemel Hempstead, UK) and visualized by electrochemilumine-
sence (ECL) detection (GE Healthcare, Little Chalfont, UK), as described [28]. The membrane
was stripped and re-probed with mouse 12G10 anti-alpha-tubulin antibody (Developmental
Studies Hybridoma Bank, University of Iowa) as a loading control.
Ex vivoGene Expression Studies
Total RNA was isolated from kidneys using the RNeasy mini kit (Qiagen, Crawley, UK) and
2 μg was used to synthesize cDNA using AffinityScript multiple temperature reverse transcrip-
tase (Agilent Technologies, Edinburgh, UK), as described [20]. cDNA templates were amplified
by quantitative PCR using SYBR Green (Applied Biosystems, California, USA) and Applied
Biosystems 7500 Fast Real-Time PCR System [20], and gene-specific primers for Kl (forward:
GCTCAACTCTCCCAGTCAGG and reverse: GTGTTCCAGAACCCAGGAAG), Cyp27b1 (forward:
TGGAGTGGACACGGTATCCA and reverse: GGTCCCAGCTGTGATCTCAGA), and the endoge-
nous house-keeping gene, Gapdh (forward: AGCGAGACCCCACTAACATC and reverse:
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GGTTCACACCCATCACAAAC). Gene expression was assessed by SYBR green detection, nor-
malized to expression of Gapdh and analyzed by the Comparative ΔΔCT method to determine
the difference in mutants relative to wild-type groups, as described [20].
Statistical Analysis
Mean values and standard deviations (SD) or standard errors of mean (SEM) were calculated
and analysis performed using unpaired Student’s t-test for independent samples in which the
Bonferroni correction for multiple testing was applied [20]. A value of p<0.05 was considered
significant for all analyses.
Results
Phenotypic Identification of Ectopic Calcification (EC) mice, Ecalc1 and
Ecalc2
Phenotype analysis of two independent G3 progeny, derived from matings between parents
and their offspring to yield autosomal recessive phenotypes, revealed, at 3 weeks of age, mice
that were smaller, and with a hunched posture when compared to the unaffected littermates
(Ecalc1 = 28 affected (11 males and 17 females), 70 unaffected (41 males and 29 females);
Ecalc2 = 10 affected (5 males and 5 females), 37 unaffected (20 males and 17 females). Thus,
~29% of Ecalc1 progeny and ~21% of Ecalc2 progeny were affected with EC, consistent with
the expected ~25% of affected progeny in an autosomal recessive trait. Further inheritance test-
ing through breeding was not possible, because affected Ecalc1 and Ecalc2mice had to be culled
by 5 weeks of age, i.e. before puberty, due to poor health. All of the affected mice from Ecalc1
and Ecalc2 had a negative Preyer reflex, thereby indicating a hearing deficit. Radiography re-
vealed that Ecalc1 and Ecalc2mice had generalised reduction of soft tissue mass, thickened zy-
gomatic arches, kyphoscoliosis, irregular widened ribs, shortened and radiolucent femora with
cortical thinning, and opacifications affecting the aorta (Fig 1), consistent with EC. In accor-
dance with welfare guidelines, further phenotypic analysis was undertaken on a single progeny
only (Ecalc1), which was aged to a maximum 5 weeks. Histological analysis with von Kossa
staining confirmed the presence of extensive aortic calcification leading to vessel occlusion;
vascular and parenchymal renal calcification; pulmonary calcification with emphysematous
changes; skin atrophy with reduced epidermal and subcutaneous fat thickness, and thickening
and calcification of the auditory ossicles (Fig 1).
Mapping of the Ecalc1 and Ecalc2 loci to chromosome 5G3 and
identification of Kl coding-region mutations
Genome-wide analysis using 91 SNP sets and DNA samples from 12 affected Ecalc1 (9 males
and 3 females) mice localised the Ecalc1 locus to a 4.0 Mb region (between 147 and 151 Mb)
flanked by rs29545151 and rs6198385 on chromosome 5G3 that contained 68 genes, of which
klotho (Kl) was the most likely candidate (Fig 2). Similar genome-wide mapping using DNA
samples from 8 affected Ecalc2 (5 males and 3 females) mice localised the Ecalc2 locus to a
11.0 Mb region (between 140 and 151 Mb) flanked by rs4225539 and rs6198385 on chromo-
some 5G3, that contained 198 genes, and amongst this Kl was the most likely candidate. DNA
sequence analysis of the entire Kl 3045-bp coding-region and exon-intron boundaries was
therefore undertaken in affected Ecalc1 and Ecalc2mice and this revealed Ecalc1mice to har-
bour a C to T transition at codon 203 within exon 1, which altered a glutamine (Gln) amino
acid residue to a stop codon; and Ecalc2mice to harbour a T to A transversion at codon 604 in
exon 4, which altered an isoleucine (Ile) residue to an asparagine (Asn) residue (Figs 2 and 3).
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Fig 1. Phenotypic features of Ecalcmice. The Ecalc1 and Ecalc2 progeny had similar phenotypic features
characterised by EC, growth retardation and reduced lifespan. In accordance with welfare guidelines,
detailed phenotypic analysis was undertaken on the Ecalc1 progeny only. Radiography of unaffected and
Mice with ENU Induced Allelic KlothoMutations
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No other DNA sequence abnormalities of the Kl gene were identified. The Gln203Stop non-
sense mutation resulted in the loss of a PstI restriction enzyme site, whilst the Ile604Asn mis-
sense mutation resulted in a loss of a DpnII restriction enzyme site, and these were used to
confirm the presence of the mutations (Fig 2). The Ile604Asn Klmissense substitution affects
an evolutionary conserved residue and represents the first mutation to be identified in the ex-
tracellular KL2 domain (Fig 3).
Functional characterization of the Gln203Stop and Ile604Asn Kl
mutations in Ecalc1 and Ecalc2mice
The Gln203Stop mutation of the Ecalc1mice (kl203X) was predicted to result in a truncated
klotho protein that would be non-functional as it lacked a transmembrane domain and most
(>75%) of the extracellular domain, and would be thus unable to localize to the plasma mem-
brane and act as a co-receptor for FGF23. Moreover, it would seem likely that the Gln203Stop
mutant transcript would undergo nonsense-mediated decay and the expression of Kl tran-
scripts in wild-type and kl203X mice was therefore investigated using quantitative reverse tran-
scriptase-PCR (qRT-PCR) of RNA obtained from the kidneys of wild-type and kl203X mice.
This revealed homozygous-affected (kl203X/203X) mice to have a 17-fold reduction of klotho ex-
pression when compared to wild-type mice (p<0.001), whilst heterozygous (kl203X/+) mice,
which did not harbour the affected phenotype, had a 2-fold reduction of klotho expression
compared to wild-types (p<0.001) (Fig 3C), consistent with the occurrence of nonsense-medi-
ated decay of mutant Kl transcripts in kl203X mice. The effects of the missense Ile604Asn Klmu-
tation, which represents the first identified mutation involving the KL2 domain (Fig 3) are
difficult to predict. The only other previously described klotho missense mutation,
(His193Arg), to date, is located in the KL1 domain and this has been demonstrated to impair
klotho protein stability [9]. We therefore investigated whether the Ile604Asn Klmutation may
impair the expression and cellular processing of klotho by in vitro transient transfection of
wild-type or Ecalc2 (kl604N)-mutant enhanced green fluorescent protein (EGFP)-tagged Kl
cDNA constructs in COS-7 cells (Fig 4). Western blot analysis of whole cell lysates obtained
from transiently transfected COS-7 cells demonstrated similar levels of expression of wild-type
or kl604N-mutant EGFP-tagged Kl constructs (Fig 4A). Treatment of transfected cell lysates
with the deglycosylating enzyme, Endo H, which cleaves high mannose N-linked glycans that
are introduced in the endoplasmic reticulum (ER), revealed the presence of Endo H-sensitive
products in both cell lysates (Fig 4A), thereby indicating that wild-type and kl604N-mutant
Asn604 klotho proteins had high mannose structures, and thus entered the ER lumen. Howev-
er, lysates from cells expressing the kl604N-mutant Asn604 klotho protein lacked Endo H-
resistant products, which were present in cells expressing wild-type klotho (Fig 4A). This
affected Ecalc1mice (5 weeks old). (A) Affected Ecalc1mice have generalised reduction of soft tissue mass,
kyphoscoliosis, widened zygomatic arches and irregular widened ribs. Dissected specimens revealing
Ecalc1mice to have: (B) flattened vertebra and sclerotic ribs; (C) patchy opacifications within the aorta; (D)
shortened radiolucent femora with cortical thinning: and (E) a shorter malleus with shortening and thickening
of its manubrium (arrowhead), a reduction in size of the foramina between the crura (arrow) in the stapes, and
the occurrence of ectopic calcification (asterisks) in the malleus and incus, when compared to unaffected
littermates. Scale bar = 200μM. (F) Haematoxylin and eosin (H&E) and Von Kossa stained sections from
affected Ecalc1mice and unaffected littermates. When compared to unaffected littermates, Ecalc1 affected
mice had: extensive aortic calcification leading to an irregular aortic lumen with widening of the medial and
adventitial wall layers; necrotic regions within the renal parenchyma that were most pronounced around
calcification foci; regions of dense calcification within the lungs that were associated with a reduced number
of alveoli and inflammatory cell infiltrates; and skin calcification leading to reduced thickness of the epidermal
(Epi) and subcutaneous fat (SCF) skin layers.
doi:10.1371/journal.pone.0122650.g001
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Fig 2. Mapping of Ecalc1 and Ecalc2 loci and identification ofKlmutations. (A) The Ecalc1 and Ecalc2 loci originated in a C57BL/6 ENU-mutagenised
male and are hence inherited with C57BL/6 alleles. The Ecalc1 locus was mapped to a 4.0 Mb region on chromosome 5 flanked by the rs29545151 and
rs6198385 SNPs (square bracket). The Ecalc2 locus was mapped to a 11.0 Mb overlapping interval between the rs4225539 and rs6198385 SNPs. The most
likely candidate gene in these intervals was Kl, which is located between rs3681853 and rs6198385, and DNA sequence analysis of Kl was therefore
undertaken. (B) A C to T transition at codon 203 was identified in affected Ecalc1mice. This altered the wild-type (WT) sequence (CAG), which encodes a
Mice with ENU Induced Allelic KlothoMutations
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suggests that the kl604N-mutant Asn604 klotho protein does not undergo the complex oligosac-
charide modifications that occur in the Golgi apparatus, but may instead be retained in the ER.
Immunofluorescence and confocal microscopy was undertaken to determine the sub-cellular
localization of wild-type and mutant klotho proteins. Wild-type (Ile604) klotho-EGFP was
found to be expressed at the plasma membrane, with some intracellular expression co-localiz-
ing with the ER marker, protein disulphide isomerase (PDI) and the Golgi matrix protein
(GM130), whereas the kl604N-mutant Asn604 klotho protein predominantly co-localized with
the ER marker, PDI (Fig 4B), thereby indicating impaired trafficking and ER retention of the
mutant protein. Thus, the Gln203Stop and Ile604Asn Kl variants were demonstrated to be
pathogenic mutations that impaired the expression or subcellular localization of the klotho
protein, and provide an explanation for the severe phenotypes and lack of viability beyond 5
weeks for both the kl203X/203X and kl604N/604N mice.
Bone and Mineral Metabolic phenotype of kl203Xmice
Kl gene abnormalities in human and mice are associated with dysregulation of bone and miner-
al metabolism, as well as EC (Table 1). The mineral metabolic abnormalities include hypercal-
caemia, hyperphosphataemia, increased circulating concentrations of 1,25 dihydroxyvitamin D
and FGF23 as well as osteopaenia. The bone and mineral metabolic abnormalities resulting
from the ENU-induced Klmutations were therefore investigated in one of the models, kl203X,
which was due to a nonsense mutation, Gln203Stop, and hence likely to be more severe than
the missense mutation, Ile604Asn of kl604N mice, although both kl203X and kl604N mutant mice
were not viable beyond 5 weeks of age. Analysis of plasma from 4–5 week old mice did not re-
veal any significant differences between heterozygous affected (kl203X/+) mice and wild-type lit-
termates (Table 2). However, male and female homozygous affected (kl203X/203X) mice had
significantly increased plasma concentrations of phosphate and alkaline phosphatase activity,
but were normocalcaemic (Table 2). There were also gender-specific differences, as female
kl203X/203X mice had significantly lower plasma glucose concentrations compared to female
wild-types, whereas male kl203X/203Xmice had significantly reduced plasma albumin concentra-
tions when compared to male wild-types (Table 2). As male and female kl203X/203Xmice were re-
vealed to be hyperphosphataemic, measurements of plasma 1,25 dihydroxyvitamin D and intact
FGF23 were undertaken. The plasma concentrations of 1,25 dihydroxyvitamin D were signifi-
cantly elevated in kl203X/203Xmice compared to wild-types (Table 2), consistent with a signifi-
cantly increased (6-fold) expression of vitamin D-1α-hydroxylase (Cyp27b1) in kl203X/203Xmice
when compared to wild-type littermates (p<0.001) (Fig 5A). Plasma intact FGF23 concentra-
tions were markedly raised in male and female kl203X/203Xmice, such that the values obtained
were above the upper limit of assay detection (Table 2). Radiography showed the femora of
kl203X/203Xmice to have reduced radiodensity and cortical thickness, consistent with osteopaenia
(Fig 1D), and DXA analysis of femora harvested frommice aged 5 weeks demonstrated male
glutamine (Gln) residue, to the mutant (m) sequence (TAG), which encodes a stop codon. The mutation resulted in the loss of a PstI restriction enzyme site
(CTGCA/G), and this was used to confirm the mutation. (C) A 449bp PCR-amplified product cleaved with PstI is predicted to yield 251bp and 198bp products
from theWT allele, whereas the mutant allele remains undigested with a resultant 449bp product. (D) Gel electrophoresis of PCR products digested with PstI
showing DNA fromWT to be homozygous for the 251bp and 198bp bands; kl203X/+ unaffected mice to be heterozygous for the 449bp and 251bp + 198bp
bands; and kl203X/203X affected mice to be homozygous for the mutant 449bp band. (E) A T to A transversion was identified at codon 604 in affected Ecalc2
mice. This altered the WT sequence (ATC), which encodes an isoleucine (Ile) residue, to the m sequence (AAC), which encodes an asparagine (Asn)
residue. The mutation resulted in the loss of a DpnII site (/GATC), and this was used to confirm the mutation. (F) A 292bp PCR-amplified product cleaved with
DpnII is predicted to yield 229bp and 63bp products from the WT allele, whereas the mutant allele remains undigested with a resultant 292bp product. (G) Gel
electrophoresis of PCR products digested with DpnII showing DNA fromWT to be homozygous for the 229bp and 63bp bands; kl604N/+ unaffected mice to be
heterozygous for the 292bp and 229bp + 63bp bands; and kl604N/604N affected mice to be homozygous for the mutant 292bp band. S is the size marker (1Kb
ladder).
doi:10.1371/journal.pone.0122650.g002
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Fig 3. Protein sequence alignment, mutation location and renal Kl gene expression. (A) Protein
sequence alignment (NCBI BLAST) of klotho residues in orthologues from 7 species and 3 paralogues,
revealed evolutionary conservation of the Ile604 residue that is mutated to Asn604 in kl604Nmice. The Ile604
residue (arrow) is either conserved as an Ile residue amongst orthologues and paralogues or conservatively
substituted with a Leu or Val residue. (B) Schematic representation of the genomic organisation of the human
and mouse klotho gene showing location of reported pathogenic coding-region mutations causing TC in man,
and common variants associated with a human ageing phenotype [9, 29]. The klotho gene consists of 5
exons (1–5). The start (ATG) and stop (TAA) codons are located in exons 1 and 5, respectively. The 5’
portion of exon 1, and the 3’ portion of exon 5 are untranslated (open boxes). The klotho protein N-terminal
signal peptide is encoded by the 5’ portion of exon 1 (black). Exons 1–4 encode the extracellular KL1 and
KL2 repeat regions (light grey) that have homology to β-glycosidases. The 5’ portion of exon 5 (dark grey)
encodes the single-pass transmembrane domain and short intracellular domain. The sites of coding-region
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and female kl203X/203Xmice, but not kl203X/+mice, to have significant reductions in bone mineral
content (BMC) (p<0.001) and bone mineral density (BMD) (p<0.001), when compared to
wild-type littermates (Fig 5B). However, the size of the femora from kl203X/203Xmice was reduced
when compared to kl203X/+ and wild-type mice, and this may contribute to the observed reduc-
tions in BMC and BMD, as measured by DXA [30]. The basis of the shortened long bones of
kl203X/203Xmice (Fig 1D) was investigated by examining endochondral ossification in the proxi-
mal tibiae from 5-week old mice. This revealed narrowing of the growth plate region (Fig 5C)
klotho mutations and variants are indicated. The previously reported loss-of-function His193Arg (H193R)
mutation and common Phe352Val/Cys370Ser (F352V/C370S) double variant that leads to a gain-of-function
are located in the extracellular KL1 domain. Klotho mutations identified in the kl203X and kl604Nmice are
highlighted in bold. The kl203XGln203Stop (Q203X) mutation is located in the KL1 domain and predicted to
lead to a truncated protein lacking the intracellular, transmembrane and extracellular KL2 domains. The
mutant Gln203Stop klotho transcript is likely to undergo nonsense-mediated decay. The kl604N Ile604Asn
(I604N) mutation represents the first pathogenic variant identified in the KL2 domain. ECD, extracellular
domain; TMD, transmembrane domain; ICD, intracellular domain. (C) Analysis of renal Kl gene expression.
RNA from whole kidneys was extracted from wild-type (WT) littermates (N = 3 males), kl203X/+ (N = 3 males)
and kl203X/203X (N = 3 males) mice, aged 4–5 weeks. Quantitative reverse transcriptase-PCR (qRT-PCR) was
used to study the expression of Kl. Samples were analysed in triplicate, and mRNA levels were normalized to
Gapdh and expressed as fold-change (mean ± SEM) compared to wild-types. The expression of Kl was
significantly reduced in kl203X/+ and kl203X/203Xmice when compared to wild-type littermates. ***p<0.001.
doi:10.1371/journal.pone.0122650.g003
Fig 4. Retention of kl604N-mutant Asn604 klotho protein within the endoplasmic reticulum. (A) Western
blot analysis of cell lysates from COS-7 cells transfected with the wild-type (WT) or kl604N-mutant (Asn604)
EGFP-tagged constructs. Wild-type and mutant klotho proteins were detected in equal amounts in the cell
lysates using the anti-EGFP antibody. Treatment with Endo H revealed undigested wild-type klotho proteins
whereas all the mutant Asn604 klotho protein was Endo H-sensitive, suggesting that the mutant Klotho
protein is retained in the endoplasmic reticulum. Anti-tubulin antibody was used as a loading control. (B)
COS-7 cells were transiently transfected with either wild-type-EGFP or mutant-EGFP (Asn604) constructs,
and counterstained with anti-PDI antibody, which immunostains the ER (red), or anti-GM130 antibody, which
immunostains the Golgi apparatus (red). DAPI was used to stain the nucleus (blue). Wild-type klotho is
expressed at the plasmamembrane, with some co-localizing with PDI and GM130, whereas the mutant
klotho co-localizes with PDI and is thus predominantly retained within the ER.
doi:10.1371/journal.pone.0122650.g004
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secondary to an ~45% reduction in the width of both the proliferative and hypertrophic epiphy-
seal zones of affected mice (Fig 5D and 5E).
Discussion
Our study describes two EC mouse mutants, designated kl203X and kl604N, which harbour germ-
line coding-region nonsense and missense Klmutations, respectively, that were induced by
ENU. This chemical mutagen is known to induce multiple mutations simultaneously [18].
However, it was unlikely that another genetic defect within the 11.0 Mb region that was estab-
lished as the location of the Ecalc1 and Ecalc2 loci (Fig 2A) could be the underlying cause of
EC. Indeed, the likelihood of another genetic cause was estimated to be<0.01, based on the fol-
lowing reasoning. The nominal ENU induced base pair mutation rate for potentially functional
mutations has been estimated to be 1 in 1.82 Mb of coding DNA in the F1 founder animals
[31], and given that<2.5% of the mouse genome is coding, it has been calculated that the prob-
ability of two functional mutations arising within a 5.0 Mb genomic region is<0.002 [32]; thus
the likelihood of functional mutations arising in addition to the Klmutations within the 11.0
Mb containing the Ecalc1 and Ecalc2 loci is<0.005. This indicates that the Ecalc1 Gln203Stop
and Ecalc2 Ile604Asn Klmutations, which were shown to result in nonsense-mediated Kl tran-
script decay and ER retention of the mutant klotho protein, respectively (Figs 3C and 4), are
highly likely to be the sole genetic defects causing EC in these mouse models. Indeed, an analy-
sis of the 198 genes within the 11.0 Mb region that contains the Ecalc1 and Ecalc2 loci (Fig 2A)
did not reveal any known phosphate-regulating genes (S1 Dataset).
Table 2. Plasma analysis of ~5 week old kl203Xmice.
Females Males
Wild-type kl203X/+ kl203X/203X Wild-type kl203X/+ kl203X/203X
Calciuma (mmol/L) 2.39±0.09
(n = 13)
2.36±0.04
(n = 15)
2.27±0.10 (n = 11) 2.24±0.07 (n = 14) 2.40±0.06 (n = 19) 2.34±0.09 (n = 16)
Phosphate (mmol/
L)
3.37±0.18
(n = 14)
3.52±0.11
(n = 15)
4.72±0.14*** (n = 9) 3.47±0.2 (n = 14) 3.66±0.17 (n = 19) 4.20±0.16**
(n = 16)
ALP (U/L) 194±19 (n = 14) 225±8 (n = 15) 501±78.7***
(n = 11)
224±31 (n = 14) 185±13 (n = 19) 432±40** (n = 16)
Albumin (g/L) 22.6±2.0 (n = 13) 25.5±0.5 (n = 15) 23.6±1.0 (n = 11) 24.3±0.5 (n = 14) 24.2±0.7 (n = 19) 21.8±0.6* (n = 16)
ALT (U/L) 27.6±4.7 (n = 12) 46.4±13.7
(n = 15)
45.6±7.6 (n = 8) 40.89±9.50
(n = 12)
35.66±6.70
(n = 16)
17.99±2.00 (n = 4)
Urea (mmol/L) 8.19±0.52 (n = 9) 7.66±0.54 (n = 7) 11.76±2.31 (n = 4) 7.15±0.58 (n = 7) 8.22±0.57 (n = 9) 9.44±0.52 (n = 6)
Glucose (mmol/L) 11.9±0.8 (n = 12) 11.5±0.5 (n = 15) 5.5±0.5*** (n = 10) 10.0±0.6 (n = 13) 11.6±1.0 (n = 16) 7.2±1.4 (n = 12)
1,25(OH)2D (pmol/L) 96±20 (n = 6) 100±13 (n = 6) 309±70** (n = 4) 115±16 (n = 5) 156±53 (n = 5) 471
b, 375b (n = 2)
FGF23 (pg/mL) 256±35 (n = 14) 363±43 (n = 13) "c (n = 9) 436±90 (n = 8) 410±39 (n = 16) "c (n = 14)
Values are expressed as mean±SEM.
aPlasma calcium concentrations were normalized to the mean plasma albumin concentration.
bPlasma 1,25-dihydroxyvitamin D concentrations were measured in two male kl203X/203X mice, and the value for each individual mouse, which is provided
in the table, is >5 SD above the mean of the male wild-type mice.
cMale and female kl203X/203X mice had plasma FGF23 concentrations that were above the upper limit of assay detection, indicative of marked FGF23
elevations. ", increased; ALP, alkaline phosphatase activity; ALT, alanine aminotransferase; FGF23, ﬁbroblast growth factor; 1,25(OH)2D,
1,25-dihydroxyvitamin D.
*p<0.05.
**p<0.01,
***p<0.001.
doi:10.1371/journal.pone.0122650.t002
Mice with ENU Induced Allelic KlothoMutations
PLOS ONE | DOI:10.1371/journal.pone.0122650 April 10, 2015 13 / 19
Fig 5. Bone andmineral metabolic phenotype of kl203Xmice. (A) Analysis of renalCyp27b1 gene
expression. RNA from whole kidneys was extracted from wild-type (WT) littermates (N = 3 males), kl203X/+
(N = 3 males) and kl203X/203X (N = 3 males) mice, aged 4–5 weeks. Quantitative reverse transcriptase-PCR
(qRT-PCR) was used to study the expression of Cyp27b1. Samples were analysed in triplicate, and mRNA
levels were normalized toGapdh and expressed as fold-change (mean ± SEM) compared to wild-types. The
expression of Cyp27b1was significantly increased in kl203X/203Xmice, but not kl203X/+mice, when compared
to wild-type littermates. ***p<0.001. (B) DXA analysis of dissected femora from 5 week old mice revealed
significantly reduced bone mineral content (BMC) and bone mineral density (BMD) in kl203X/203Xmice when
compared to kl203X/+ and wild-type littermates. ***p<0.001. (C-E) Histological analysis of wild-type and
kl203X/203X growth plates were undertaken by staining paraffin embedded proximal tibial sections with Alcian
blue (cartilage) and van Gieson (osteoid). This revealed growth plate narrowing in kl203X/203Xmice (C), which
is due to a significantly reduced height of the proliferating zone (PZ) and hypertrophic zone (HZ) (D and E).
The height of the reserve zone (RZ) was unaffected. ***p<0.001.
doi:10.1371/journal.pone.0122650.g005
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ENU-derived kl203X/203X mice were confirmed as a model for klotho deficiency as they had
markedly reduced renal Kl expression in association with hyperphosphataemia, raised circulat-
ing 1,25 dihydroxyvitamin D and FGF23 concentrations, and widespread EC. The heterozy-
gous affected (kl203X/+) mice did not exhibit any clinical or biochemical abnormalities, and
these findings are in keeping with other TC mouse models, in which heterozygous mice are un-
affected [10–12, 22], and consistent with TC being an autosomal recessive disorder [6]. The
phenotypes of kl203X/203X mice are in keeping with reported klotho mouse mutants and a TC
patient harbouring a germline missense KLmutation (Table 1) [9, 11, 22, 33, 34], and highlight
the central importance of klotho in systemic mineral metabolism. The kl203X/203X mice also
share a complex skeletal phenotype with the klotho mouse models and TC patient that is char-
acterised by the combined occurrence of osteopaenia and sclerotic or hyperostotic lesions [9,
11, 22]. Bone histology of klotho deficient mice previously revealed the osteopaenia to be
caused by cortical thinning of long bone diaphyses, whereas the epiphyses may paradoxically
have an increased BMD and trabecular bone volume [35, 36]. Moreover, hypomineralisation
and increased osteoid formation has been previously observed within the metaphyseal regions
of klotho deficient mice [22, 37], and although we did not assess osteoid formation by tetracy-
cline labelling due to the young age and poor health of affected mice, our findings of elevated
alkaline phosphatase activity in kl203X/203X mice are consistent with klotho deficiency being as-
sociated with an osteomalacic phenotype. Furthermore, the shortened femora of kl203X/203X
mice was revealed to be associated with narrowing of the growth plate hypertrophic and prolif-
erative zones, and this may be a consequence of hyperphosphataemia-induced chondrocyte ap-
optosis [38]. The present study has also revealed the hearing deficit of kl203X/203X mice to
represent a novel skeletal manifestation of klotho deficiency that is characterised by sclerosis of
the auditory ossicles. Similar abnormalities of the auditory ossicles have recently been reported
in Fgf23 null mice [39]. However, hearing deficits have not been described in TC patients har-
bouring FGF23 or GALNT3mutations, or in the sole TC patient reported to date with a KL
mutation [8, 9, 40]. Moreover, periarticular calcification, which is a hallmark feature of TC in
humans, was not detected in kl203X/203X mice or reported in other TC mouse models [10–12,
22]. Periarticular calcification has been described in EC mouse models that harbour abnormali-
ties of the Enpp1 or Ank genes [41, 42]. However, these mice were assessed in adulthood (4
months of age), whilst TC mice with ablated Fgf23 or Kl alleles do not survive past 3 months of
age [11, 12, 22]. Thus, the lack of periarticular calcification in TC mice may potentially be a
consequence of their young age or represent a species-specific difference. The kl203X/203X mice
displayed phenotypic differences to the reported mouse models and TC patient with klotho
mutations (Table 2) [9, 11, 22, 33, 34]. In particular, mild hypercalcaemia, which had been re-
ported to arise in association with increased renal synthesis of 1,25 dihydroxyvitamin D in
klotho deficient mice [43], or from hyperparathyroidism as occurred in the KLmutation pa-
tient [9], was absent in kl203X/203X mice. We postulate that kl203X/203X mice compensate for the
hypercalcaemic effects of increased circulating 1,25 dihydroxyvitamin D concentrations by
mounting a hypercalciuric response. Although urinary calcium excretion could not be
assessed because of the poor health and reduced life of the kl203X/203X mice, renal parenchymal
calcification was detected (Fig 1F), which may be suggestive of hypercalciuria. Moreover, male
kl203X/203X mice were hypoalbuminaemic, and this finding, which may represent a malnour-
ished state, has not been reported in other klotho deficient mice or in the TC patient with a KL
mutation [9, 11, 22]. The ENU-derived kl203X/203X mice and other klotho deficient mouse mod-
els have a more severe phenotype than that reported for the patient harbouring a KLmutation
[9]. Thus, klotho deficient mice have a reduced lifespan and develop multi-systemic abnormali-
ties that include: growth retardation, hypoglycaemia due to increased insulin sensitivity [11,
44], a generalised reduction of white adipose tissue that may be a consequence of impaired
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adipocyte maturation [11, 45], and senescence-related traits such as pulmonary emphysema
and skin atrophy, which are considered to arise from calcium deposition that induces loss
of collagen fibres and progressive deterioration of tissue architecture [11, 22, 46]. These extra-
skeletal manifestations appear to be species-specific, as they have not been reported in
patients with TC [8, 9, 40], and intriguingly it has been postulated that humans may be able to
partially compensate for the effects of klotho deficiency on phosphate homeostasis, thereby
minimizing the severity of the multi-systemic hyperphosphataemic phenotype [9]. Indeed,
hyperphosphataemia appears to be central to the pathogenesis of many of these klotho mouse
mutant traits, as they are successfully rectified following administration of a reduced phosphate
diet [47], or by genetic intervention such as ablation of Cyp27b1 to lower circulating phosphate
concentrations [34]. The precise cause of premature death in the ENU-derived klotho mutants
and in other klotho deficient mice has not been elucidated. Possible aetiologies include exten-
sive vascular calcification leading to arterial occlusion or arteriosclerosis-mediated hyperten-
sion and cardiac failure, hypoglycaemia, or respiratory insufficiency due to emphysema
[11, 22].
The ENU derived kl203X mice harbour a germline Gln203Stop Klmutation that was pre-
dicted to lead to nonsense-mediated decay of the Kl transcript or result in a non-functional
truncated protein lacking the transmembrane and extracellular KL2 domains. The functional
consequences of the kl604N Ile604Asn Klmutation, which is located in the extracellular KL2 do-
main, were more difficult to predict, as the molecular basis of klotho protein activity has yet to
be elucidated and crystal structure information is not available. Some insights into klotho
structure-function have been provided by studies of missense substitutions located in the extra-
cellular KL1 domain (Fig 3B). Indeed, in vitro functional expression analyses of the human
TC-associated His193Arg klotho mutation and a common polymorphic klotho variant com-
prised of a double missense substitution (Phe352Val/Cys370Ser), which is associated with an
ageing phenotype [29], have revealed key KL1 residues that participate in protein-protein in-
teractions with the FGFR and FGF23; thus the His193Arg mutation led to a decrease in the af-
finity of klotho for FGFR and FGF23 [9], whereas the common Phe352Val/Cys370Ser variant
enhanced this interaction and promoted FGF23-mediated signal transduction [48]. The extra-
cellular KL1 and KL2 domains may also facilitate the cleavage of oligo- and polysaccharides as
they each share up to 40% homology with β-glycosidase enzymes, and the klotho protein has
previously been revealed to activate the renal TRPV5 calcium channel by removing sialic acid
residues from its N-linked glycan chains [49]. The reported His193Arg mutation is located
within the predicted catalytic pocket of the KL1 domain, and is considered to destabilise the
tertiary structure of this domain, thereby leading to reduced klotho expression and secretion
[9]. Our in vitro functional expression studies demonstrated the Ile604Asn klotho mutant to be
retained within the ER, highlighting that this missense mutation also likely impairs protein
folding and stability. Analysis of the crystal structure of a human paralogue known as klotho-
related protein, which has β-glucosidase activity [50], revealed the wild-type Ile604 residue to
be located within a region of the KL2 domain that may participate in glucosidase activity by
promoting transition states involved in the hydrolysis of β-glucosides [51], and we postulate
that the substitution of the non-polar Ile residue with a polar Asn residue may alter the struc-
tural conformation and stability of the KL2 domain.
In summary, our study has established two novel mouse models with EC and phenotypic
features associated with premature ageing, which are due to ENU induced nonsense
(Gln203Stop) and missense (Ile604Asn) mutations of the Kl gene. These mouse models will
help to further elucidate the molecular basis of klotho function and characterise the role of
klotho in the renal regulation of phosphate metabolism.
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